Effects of Electrical Stimulation on Facial Paralysis Recovery after Facial Nerve Injury: A Review on Preclinical and Clinical Studies.
Myung Chul YooJeong Hee KimYong Jun KimJunyang JungSung Soo KimSang Hoon KimSeung Geun YeoPublished in: Journal of clinical medicine (2023)
Various methods have been used to improve function and manage facial nerve injury. Although electrical stimulation therapy is frequently used to treat facial paralysis, its effects have been found to vary and no clear standards have been developed. The current review describes the results of preclinical and clinical studies evaluating the effectiveness of electrical stimulation therapy in promoting the recovery of a peripheral facial nerve injury. Evidence is presented showing the efficacy of electrical stimulation in promoting nerve regeneration after peripheral nerve injuries in both animal models and human patients. The ability of electrical stimulation to promote the recovery of facial paralysis was found to depend on the type of injury (compression or transection), the species of animal tested, the type of disease, the frequency and method of electrical stimulation, and the duration of the follow-up. Electrical stimulation, however, can also have potential negative outcomes, such as reinforcing synkinesis, including mistargeted axonal regrowth via inappropriate routes; excessive collateral axonal branching at the lesion site; and multiple innervations at neuromuscular junctions. Because of the inconsistencies among studies and the low quality of evidence, electrical stimulation therapy is not currently regarded as a primary treatment of facial paralysis in patients. However, understanding the effects of electrical stimulation, as determined in preclinical and clinical studies, is important for the potential validity of future research on electrical stimulation.
Keyphrases
- spinal cord injury
- peripheral nerve
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- stem cells
- randomized controlled trial
- type diabetes
- metabolic syndrome
- physical activity
- single molecule
- risk assessment
- patient reported outcomes
- bone marrow
- mesenchymal stem cells
- climate change
- weight gain